Treatments · Entity Annotation Prototype (beta)

1articles mentioning treatments

2treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: anti-PD-1 immunotherapy ×

anti-PD-1 immunotherapy

This treatment is selected. Its supporting articles are shown below.

anti-PD-1 immunotherapy1

Articles mentioning anti-PD-1 immunotherapy

1 articles · page 1 of 1

688 RAS(ON) inhibitors induce immunogenic cell death, promote antitumor immunity, and synergize with anti-PD-1 immunotherapy in a RAS Mutant NSCLC model

jitc · abstract · 2025-11-04 · 2 matching annotations

79.7%

anti-PD-1 immunotherapy immunotherapy Daraxonrasib elironrasib pembrolizumab NSCLC

…y of response and complete tumor regressions when combined with anti-PD-1 immunotherapy.Conclusions Simultaneously inducing cancer cell death and activ…

Browse treatments

anti-PD-1 immunotherapy

Articles mentioning anti-PD-1 immunotherapy

688 RAS(ON) inhibitors induce immunogenic cell death, promote antitumor immunity, and synergize with anti-PD-1 immunotherapy in a RAS Mutant NSCLC model